Holen Sie sich die Stockscreener-App
5.90
1.03%
0.06
Handel nachbörslich:
6.00
0.10
+1.69%
Schlusskurs vom Vortag:
$5.84
Offen:
$5.86
24-Stunden-Volumen:
243.22K
Relative Volume:
2.09
Marktkapitalisierung:
$503.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.64M
KGV:
-13.72
EPS:
-0.43
Netto-Cashflow:
$-39.43M
1W Leistung:
+19.19%
1M Leistung:
+51.67%
6M Leistung:
+79.33%
1J Leistung:
+76.12%
1-Tages-Spanne:
$5.57
$5.98
1-Wochen-Bereich:
$4.75
$5.98
52-Wochen-Spanne:
$2.30
$5.98
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Firmenname
Alpha Tau Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie DRTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
5.90 | 497.94M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-15 | Eingeleitet | Citigroup | Buy |
| 2023-04-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-04-08 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-04 | Eingeleitet | Citigroup | Buy |
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026 - TipRanks
Alpha Tau reports new positive results in two upcoming presentations - MarketScreener
Pancreatic cancer trial finds immune-sparing radiation with 81% disease control - Stock Titan
Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating - Investing.com
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical - TipRanks
Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation - The Globe and Mail
Bond Watch: Is Alpha Tau Medical Ltd stock a buy before product launchesJuly 2025 Gainers & Long-Term Capital Growth Strategies - moha.gov.vn
Alpha Tau submits first pre-market approval module to the FDA - MarketScreener
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy - TipRanks
Alpha Tau submits PMA module to FDA for Alpha DaRT - TipRanks
New radiation implant edges closer for tough-to-treat skin cancer patients - Stock Titan
What drives Alpha Tau Medical Ltd stock priceSwing Trading Watchlist & High Return Capital Gains - earlytimes.in
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Graphite India Limited At Decision Level — Rebound or ResistanceSupport Zone Identification & Double Digit Profit Strategies - bollywoodhelpline.com
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 58.8% in December - MarketBeat
Pharma News: Can Alpha Tau Medical Ltd Equity Warrant stock hit record highs again2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
How supply chain issues affect Alpha Tau Medical Ltd. stock2025 Market Overview & AI Driven Price Predictions - Улправда
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium - MSN
Will Alpha Tau Medical Ltd. stock attract more institutional investorsPortfolio Performance Report & Accurate Trade Setup Notifications - Улправда
Will Alpha Tau Medical Ltd. Equity Warrant stock sustain high P E ratios2025 Retail Activity & AI Based Trade Execution Alerts - Улправда
Entry Recap: How supply chain issues affect Alpha Tau Medical Ltd. stockJuly 2025 Earnings & Weekly High Potential Alerts - Улправда
Why Alpha Tau Medical Ltd. stock remains a top recommendationBuy Signal & Intraday High Probability Setup Alerts - Улправда
Will Alpha Tau Medical Ltd. stock deliver shareholder valueQuarterly Profit Review & Verified Short-Term Plans - Улправда
Earnings Miss: How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stock2025 Sector Review & Smart Swing Trading Alerts - Улправда
Market Recap: What insider trading reveals about Alpha Tau Medical Ltd. stockJuly 2025 Drop Watch & Risk Managed Investment Signals - Улправда
Alpha Tau Medical’s innovative cancer treatment study update: A potential game-changer - MSN
Is Alpha Tau Medical Ltd. stock a buy before product launches2025 AllTime Highs & Fast Gain Swing Alerts - Bölüm Sonu Canavarı
Will Alpha Tau Medical Ltd. Equity Warrant stock outperform Nasdaq index2025 Volume Leaders & AI Powered Market Trend Analysis - Улправда
Why Alpha Tau Medical Ltd. stock is seen as undervaluedTrade Volume Report & Stock Timing and Entry Methods - Улправда
Will Alpha Tau Medical Ltd. stock benefit from infrastructure spendingQuarterly Earnings Summary & AI Optimized Trade Strategies - DonanımHaber
Will Alpha Tau Medical Ltd. stock attract ESG investorsWeekly Stock Report & Daily Volume Surge Signals - Улправда
How Alpha Tau Medical Ltd. Equity Warrant stock performs during Fed tightening cyclesWeekly Profit Recap & Long-Term Growth Portfolio Plans - DonanımHaber
Aug Levels: Will Alpha Tau Medical Ltd. stock attract more institutional investorsJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Is Alpha Tau Medical Ltd. stock positioned for long term growthJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings seasonJuly 2025 News Drivers & Weekly Sector Rotation Insights - Улправда
Is Alpha Tau Medical Ltd. stock positioned well for digital economyBond Market & Breakout Confirmation Alerts - Улправда
Buyout Rumor: Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings season2025 Technical Overview & Free Real-Time Market Sentiment Alerts - Улправда
Will Alpha Tau Medical Ltd. stock outperform tech sector in 2025Market Risk Summary & Accurate Intraday Trade Tips - Улправда
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch - TipRanks
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference - TipRanks
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference - The Manila Times
Alpha Tau Medical (NASDAQ: DRTS) to present at J.P. Morgan 2026 event - Stock Titan
Risk Report: Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings season2025 Market Outlook & Consistent Profit Trade Alerts - Улправда
How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stockJuly 2025 Final Week & Precise Buy Zone Identification - Улправда
What insider trading reveals about Alpha Tau Medical Ltd. stockWeekly Risk Report & Weekly Stock Breakout Alerts - Улправда
Alpha Tau Medical’s innovative prostate cancer therapy: study completion update - MSN
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer - TipRanks
Death Cross: Will Alpha Tau Medical Ltd Equity Warrant stock maintain growth story2025 Top Gainers & Risk Controlled Stock Alerts - moha.gov.vn
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update - TipRanks
Finanzdaten der Alpha Tau Medical Ltd-Aktie (DRTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
28.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):